FDA rejects MDMA for treating PTSD, calls for redo of study, drugmaker says
FDA rejects MDMA for treating PTSD, calls for redo of study, drugmaker sayshttps://wpnnradio.com/wp-content/themes/movedo/images/empty/thumbnail.jpg150150adminadminhttps://secure.gravatar.com/avatar/790df65a416873c3f0501d984b0b24a2f32bf2af0d1509085b901ade4bbb36e7?s=96&d=mm&r=g
Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take “several years.” source
